000 03081nam a22003495i 4500
999 _c81698
_d81698
_x1
001 81698
003 ES-MaUEC
005 20230221040151.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 141028s2015 ne | s |||| 0|eng d
020 _a9789401794695
024 7 _a10.1007/978-94-017-9469-5
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQK495.L25
_b2015 EB
245 0 0 _aDan Shen (Salvia miltiorrhiza) in Medicine
_nVolume 1,
_pBiology and Chemistry
_cedited by Xijun Yan.
264 1 _aDordrecht, Netherlands
_bSpringer
_c2015
300 _a1 recurso en línea (XXX, 212 p.)
_b94 ilustraciones, 2 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aMateria Medica and Plant Resource -- Distribution and Habitat of Danshen -- Biological Characters of Danshen -- A Study on the Cultivation of Danshen -- Danshenâ€{u3829}n vitro Culture -- Genetics and Breeding of Danshen -- Water Soluble Components of Danshen -- Liposoluble chemical constituents in Danshen.
520 _aThis book reviews research on Dan Shen, compiles data from clinical trials and biological experiments, and summarizes the latest research advances. It covers the medicinal herb, herbal pieces, and new proprietary drugs that contain it; it also covers simple and compound, traditional and contemporary formulas, and addresses a broad range of subjects, including: standardized cultivation;Â{u08A9}odiversity; effective substances and their biological activities; quality control; and clinical trials. The book goes on to present the clinical trials on Dantonic, especially focusing on its therapeutic effects for coronary heart disease. It discusses compound prescriptions and compatibilities, from the herbal piece level to composition level, and describes approaches to research on modern Chinese medicine. Â{u05AF}lume 1 describes the biology and chemistry of Dan Shen, while Volume 2 focuses on pharmacology and quality control. Volume 3 describes the clinical research on Dan Shen. ÂŤitor Xijun Yan is the President of Tianjin Tasly Group and a Member of the TCM Standardization Technical Committee. Gathering contributions from more than 100 authors working in the field of pharmaceutical and clinical research, the book presents and analyzes the available information from multiple aspects, reflects the current status of Dan Shen research, and offers an essential reference work for further research and development.
988 _aEBOOK, EBSPRINGER
650 7 _aFarmacología
_2embne
_9137893
650 7 _9671889
_aSalvias
_2embne
700 1 _aYan, Xijun
_eeditor literario
_994275
_0Local
710 2 _aSpringerLink (Online service)
_0Local
_9106996
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-9469-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b11/2020
_dz
_eIG
_feng
_gne
_h0